TipRanks
Go Ultimate55% OFF

Pharmaust Limited (NUZ) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

NUZ Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Pharmaust Limited in the past 3 months

NUZ Stock 12 Month Forecast

AUD 0.20▲(132.56% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Pharmaust Limited in the last 3 months. The average price target is AUD 0.20 with a high forecast of AUD 0.20 and a low forecast of AUD 0.20. The average price target represents a 132.56% change from the last price of AUD 0.09.
Highest Price TargetAUD 0.20Average Price TargetAUD 0.20Lowest Price TargetAUD 0.20

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for AU:NUZ
Price TargetFollowArticle
MorgansAUD 0.20buy132.56%UpsideReiterated10/06/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Pharmaust Limited

3 Months
Success Rate6/11 ratings generated profit
55%
Average Return
+6.25%

Copying Iain Wilkie's trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of +6.25% per trade.

1 Year
Success Rate5/11 ratings generated profit
45%
Average Return
-4.68%

Copying Iain Wilkie's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of -4.68% per trade.

2 Years
Success Rate4/11 ratings generated profit
36%
Average Return
-9.00%

Copying Iain Wilkie's trades and holding each position for 2 Years would result in 36.36% of your transactions generating a profit, with an average return of -9.00% per trade.

NUZ Analyst Recommendation Trends

00.511.52Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for NUZ
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy21222
Buy00000
Hold00000
Sell00000
Strong Sell00000
total21222

In the current month, NUZ has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NUZ average Analyst price target in the past 3 months is 0.20.

NUZ Financial Forecast

AUD -2AUD -1.5AUD -1AUD -0.5AUD 0Q4 2025Q4 2026Q2 2027
ConsensusAUD -0.01

NUZ Earnings Forecast

Next quarter’s earnings estimate for NUZ is -AUD 0.01 with a range of ― to ―. The previous quarter’s EPS was -AUD 0.01. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

AUD -1AUD -0.5AUD 0AUD 0.5AUD 1Q4 2025Q4 2026Q2 2027
ConsensusAUD 0.00

NUZ Sales Forecast

Next quarter’s sales forecast for NUZ is AUD 0 with a range of ― to ―. The previous quarter’s sales results were AUD 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

NUZ Stock Forecast FAQ

What is AU:NUZ’s average 12-month price target, according to analysts?
Based on analyst ratings, Pharmaust Limited’s 12-month average price target is AU$0.20.
What is AU:NUZ’s upside potential, based on the analysts’ average price target?
Pharmaust Limited has 132.56% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Pharmaust Limited a Buy, Sell or Hold?
Pharmaust Limited has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Pharmaust Limited’s share price target?
The average share price target for Pharmaust Limited is AU$0.20. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is AU$0.20, and the lowest forecast is AU$0.20. The average share price target represents a 132.56% increase from the current price of AU$0.086.
What do analysts say about Pharmaust Limited?
Pharmaust Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Pharmaust Limited?
To buy shares of AU:NUZ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.